Chemours Investors Notified of Class Action Deadline Following 18% Stock Drop

Chemours faces a class action lawsuit alleging securities fraud after an 18% stock drop linked to claims of misrepresented Opteon product demand. Investors are urged to contact BFA Law before the December 7 lead plaintiff deadline.